Article: BTG Announces Licensing and Research Agreement with the University of Illinois at Chicago to Develop Novel Therapy for Treatment of Sleep Apnea.

WEST CONSHOHOCKEN, Pa. -- Innovative pharmacological approach for the treatment of sleep-related breathing disorder

BTG (LSE: BGC), the intellectual property and technology commercialization company, today announced that it has signed a licensing and research agreement with the University of Illinois at Chicago (UIC) to further develop a novel pharmacological therapy for the treatment of sleep apnea. BTG plans to invest in the development of this innovative therapy to expand its portfolio of therapeutic programs, particularly in the area of drug repositioning. Under the terms of the agreement, UIC grants BTG specific exclusive rights to intellectual property and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!